Last update 09 Sep 2026

Autologous Tumor Infiltrating Lymphocytes(Vastra Gotaland Region)

Overview

Basic Info

Drug Type
TIL therapy
Synonyms-
Target-
Action-
Mechanism
Immunologic cytotoxicity, Lymphocyte replacements
Therapeutic Areas
NeoplasmsEye DiseasesSkin and Musculoskeletal Diseases+ [1]
Active Indication
Liver metastasesMelanoma, Cutaneous MalignantMetastatic melanoma+ [1]
Inactive Indication-
Originator Organization
Region Västra Götaland
Active Organization
Region Västra Götaland
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Autologous Tumor Infiltrating Lymphocytes(Vastra Gotaland Region)
NCT07183852
/ Not yet recruitingPhase 1IIT
Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma
NCT05903937
/ Not yet recruitingPhase 1IIT
Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes Preconditioned With Percutaneous Hepatic Perfusion With Melphalan in Patients With Melanoma and Liver Metastases
100 Clinical Results associated with Autologous Tumor Infiltrating Lymphocytes(Vastra Gotaland Region)
Login to view more data
100 Translational Medicine associated with Autologous Tumor Infiltrating Lymphocytes(Vastra Gotaland Region)
Login to view more data
100 Patents (Medical) associated with Autologous Tumor Infiltrating Lymphocytes(Vastra Gotaland Region)
Login to view more data
100 Deals associated with Autologous Tumor Infiltrating Lymphocytes(Vastra Gotaland Region)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Liver metastasesPhase 1-
Region Västra Götaland
31 Jan 2027
Melanoma, Cutaneous MalignantPhase 1-
Region Västra Götaland
01 Jan 2027
Metastatic melanomaPhase 1-
Region Västra Götaland
01 Jan 2027
Uveal MelanomaPhase 1-
Region Västra Götaland
01 Jan 2027
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free